Abstract
The novel severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2; also known as 2019-nCoV) has played havoc worldwide, beginning with Wuhan, China in December 2019. As of 17 March 2020, there are 153 countries who have reported cases of infection caused by this virus [i.e., coronavirus disease-2019 (COVID-19)], with Italy becoming the new epicentre [1]. COVID-19 is a global public health emergency, and could cause devastating health issues during pregnancy. Pregnant women have a high propensity to acquire this infection due to their altered physiological and immunological function.
| Original language | English |
|---|---|
| Pages (from-to) | 246-249 |
| Number of pages | 4 |
| Journal | Drugs and Therapy Perspectives |
| Volume | 36 |
| Issue number | 6 |
| Early online date | 9 Apr 2020 |
| DOIs |
|
| Publication status | Published - 1 Jun 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Preventive measures and management of COVID‑19 in pregnancy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver